Lonza to acquire five US manufacturing sites from Merck KGaA
Lonza has entered a definitive agreement to purchase five US contract development and manufacturing organisation (CDMO) sites from Merck KGaA,…
All articles by Srivani Venna
Srivani Venna
-
-
Bavarian Nordic secures four-year UK vaccine supply deal
Bavarian Nordic has secured a four-year contract from the UK Government to supply its MVA-BN vaccine, used for the prevention…
-
Pelthos and Castle Creek plan merger to target skin diseases
Pelthos Therapeutics has agreed to merge with Castle Creek Biosciences to form a new biotechnology company that will focus on…
-
Inovio’s Voceryq receives FDA accelerated approval for RRP
Inovio has secured accelerated approval from the US Food and Drug Administration (FDA) for Voceryq to minimise the frequency of…
-
Daiichi Sankyo, MSD withdraw cancer drug application
Daiichi Sankyo and Merck & Co (MSD) have voluntarily withdrawn their biologics license application (BLA) for ifinatamab deruxtecan, aimed at…
-
Mirum and Incyte’s Atebrioz approved for FOP in US
The US Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals and Incyte’s Atebrioz (zilurgisertib) for the treatment of fibrodysplasia…
-
Gossamer Bio announces $250m in funding to advance seralutinib
Gossamer Bio has announced a private placement agreement valued at up to $250m, including $150m of committed capital intended to…
-
Johnson & Johnson’s multiple myeloma treatment secures EC approval
The European Commission (EC) has approved an extended use of Johnson & Johnson's Tecvayli (teclistamab), along with daratumumab, to treat…
-
Evotec and Odyssey collaborate on AI-enabled R&D
Evotec and Odyssey Therapeutics have announced a strategic AI-enabled research and development (R&D) partnership to explore new treatments for autoimmune and…
-
Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases. These…